Provided by Tiger Fintech (Singapore) Pte. Ltd.

BIOSTAR PHARM-B

12.500
-2.940-19.04%
Volume:287.40K
Turnover:3.63M
Market Cap:4.56B
PE:-21.56
High:14.320
Open:13.140
Low:12.000
Close:15.440
Loading ...

Beijing Biostar Pharmaceuticals Cancer Drug Receives US FDA Approval

MT Newswires Live
·
06 Feb

BRIEF-Beijing Biostar Pharmaceuticals Announces Approval Of Utidelone Capsule By U.S. FDA

Reuters
·
05 Feb

Beijing Biostar Pharmaceuticals - Approval of Utidelone Capsule in Phase Ii/Iii International Multi-Center Clinical Study by U.S. FDA

THOMSON REUTERS
·
05 Feb

Weak Financial Prospects Seem To Be Dragging Down CLP Holdings Limited (HKG:2) Stock

Simply Wall St.
·
07 Jan

Shareholders in CLP Holdings (HKG:2) are in the red if they invested five years ago

Simply Wall St.
·
17 Dec 2024

Biostar Pharma Grants Baheal Medical China Marketing Rights to Breast Cancer Drug

MT Newswires Live
·
14 Nov 2024

BRIEF-Beijing Biostar Pharmaceuticals Says To Grant Baheal Zhihe Exclusive Marketing Rights

Reuters
·
14 Nov 2024

Beijing Biostar Pharmaceuticals - Beijing Baheal Zhihe Medical Achievement Transformation Service to Pay Co Down Payment of RMB50 Mln

THOMSON REUTERS
·
14 Nov 2024

Beijing Biostar Pharmaceuticals Co Ltd - to Grant Baheal Zhihe Exclusive Right to Provide Marketing Service for Utidelone Injection

THOMSON REUTERS
·
14 Nov 2024

Are Investors Undervaluing CLP Holdings Limited (HKG:2) By 32%?

Simply Wall St.
·
11 Nov 2024

Beijing Biostar Pharmaceutical Surges in Hong Kong Debut After HK$196 Million IPO

MT Newswires Live
·
31 Oct 2024

Hong Kong Stocks Extend Losses; Beijing Biostar Pharmaceuticals Soars 30% in Debut

MT Newswires Live
·
31 Oct 2024

Stock Track | Biostar Pharmaceuticals Soars 61.87% in Market Debut After Successful $344 Million IPO

Stock Track
·
31 Oct 2024

Stock Track | Biostar Pharmaceuticals Soars 30% Following Successful $16 IPO Pricing

Stock Track
·
31 Oct 2024

Shares of Beijing Biostar Pharmaceuticals Set to Open at HK$21.50 Each in Hong Kong Debut VS IPO Price HK$16 Apiece

THOMSON REUTERS
·
31 Oct 2024

BRIEF-Beijing Biostar Pharmaceuticals Announces Final Offer Price Under Global Offering

Reuters
·
30 Oct 2024